Healthcare provider profile · identity verified

Kerry Lee Partis, MD

Family Practice · OAK ISLAND, NC · NPI 1942437256

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	880	242
Atorvastatin Calcium	Atorvastatin Calcium	801	220
Levothyroxine Sodium	Levothyroxine Sodium	562	144
Amlodipine Besylate	Amlodipine Besylate	544	149
Lisinopril	Lisinopril	511	141
Omeprazole	Omeprazole	419	117
Hydrochlorothiazide	Hydrochlorothiazide	402	120
Losartan Potassium	Losartan Potassium	332	90
Pravastatin Sodium	Pravastatin Sodium	267	78
Pantoprazole Sodium	Pantoprazole Sodium	259	78
Simvastatin	Simvastatin	254	64
Metoprolol Succinate	Metoprolol Succinate	251	68
Trazodone Hcl	Trazodone Hcl	246	76
Metformin Hcl Er	Metformin Hcl	233	69
Gabapentin	Gabapentin	191	61
Ezetimibe	Ezetimibe	186	61
Metformin Hcl	Metformin Hcl	185	47
Montelukast Sodium	Montelukast Sodium	166	43
Sertraline Hcl	Sertraline Hcl	158	40
Duloxetine Hcl	Duloxetine Hcl	149	38
Escitalopram Oxalate	Escitalopram Oxalate	148	46
Alprazolam	Alprazolam	147	56
Fluticasone Propionate	Fluticasone Propionate	136	41
Allopurinol	Allopurinol	135	38
Tamsulosin Hcl	Tamsulosin Hcl	126	41
Bupropion Xl	Bupropion Hcl	123	31
Citalopram Hbr	Citalopram Hydrobromide	122	33
Synthroid	Levothyroxine Sodium	110	25
Venlafaxine Hcl Er	Venlafaxine Hcl	109	28
Albuterol Sulfate Hfa	Albuterol Sulfate	108	46
Alendronate Sodium	Alendronate Sodium	106	36
Fluoxetine Hcl	Fluoxetine Hcl	105	33
Zolpidem Tartrate	Zolpidem Tartrate	102	40
Atenolol	Atenolol	96	24
Ozempic	Semaglutide	92	27
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	89	21
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	82	70
Valsartan	Valsartan	78	20
Metoprolol Tartrate	Metoprolol Tartrate	77	21
Valacyclovir	Valacyclovir Hcl	75	30
Meloxicam	Meloxicam	72	23
Lorazepam	Lorazepam	66	28
Tizanidine Hcl	Tizanidine Hcl	66	18
Clonazepam	Clonazepam	65	16
Furosemide	Furosemide	65	22
Glimepiride	Glimepiride	62	20
Clopidogrel	Clopidogrel Bisulfate	61	16
Benazepril Hcl	Benazepril Hcl	60	14
Potassium Chloride	Potassium Chloride	60	20
Celecoxib	Celecoxib	59	21
Estradiol	Estradiol	59	25
Olmesartan Medoxomil	Olmesartan Medoxomil	58	16
Irbesartan	Irbesartan	57	15
Paroxetine Hcl	Paroxetine Hcl	57	13
Pioglitazone Hcl	Pioglitazone Hcl	57	17
Carvedilol	Carvedilol	55	15
Spironolactone	Spironolactone	55	17
Glipizide	Glipizide	53	16
Lovastatin	Lovastatin	51	13
Buspirone Hcl	Buspirone Hcl	50	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	50	20
Amitriptyline Hcl	Amitriptyline Hcl	49	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	49	15
Diazepam	Diazepam	48	17
Eliquis	Apixaban	46	18
Prednisone	Prednisone	46	29
Doxycycline Monohydrate	Doxycycline Monohydrate	43	38
Famotidine	Famotidine	41	14
Mounjaro	Tirzepatide	41	11
Breo Ellipta	Fluticasone/Vilanterol	38	suppressed
Methylprednisolone	Methylprednisolone	37	34
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	37	30
Wixela Inhub	Fluticasone Propion/Salmeterol	37	suppressed
Donepezil Hcl	Donepezil Hcl	36	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	35	31
Paxlovid	Nirmatrelvir/Ritonavir	35	34
Temazepam	Temazepam	34	suppressed
Diclofenac Sodium	Diclofenac Sodium	33	12
Fluconazole	Fluconazole	33	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	33	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	32	suppressed
Ropinirole Hcl	Ropinirole Hcl	31	suppressed
Xarelto	Rivaroxaban	31	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	30	suppressed
Farxiga	Dapagliflozin Propanediol	30	suppressed
Tramadol Hcl	Tramadol Hcl	30	12
Bupropion Hcl Sr	Bupropion Hcl	29	suppressed
Acyclovir	Acyclovir	28	12
Ondansetron Odt	Ondansetron	28	17
Pregabalin	Pregabalin	28	suppressed
Nystatin	Nystatin	25	14
Oxybutynin Chloride Er	Oxybutynin Chloride	24	suppressed
Ventolin Hfa	Albuterol Sulfate	24	suppressed
Chlorthalidone	Chlorthalidone	23	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	23	suppressed
Primidone	Primidone	23	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	23	18
Warfarin Sodium	Warfarin Sodium	23	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	22	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	22	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	22	suppressed
Eszopiclone	Eszopiclone	21	suppressed
Finasteride	Finasteride	21	suppressed
Klor-Con M20	Potassium Chloride	20	suppressed
Propranolol Hcl	Propranolol Hcl	20	suppressed
Topiramate	Topiramate	20	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	19	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	19	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Lamotrigine	Lamotrigine	19	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	18	suppressed
Spiriva Handihaler	Tiotropium Bromide	18	suppressed
Amoxicillin	Amoxicillin	17	suppressed
Cephalexin	Cephalexin	17	13
Glipizide Er	Glipizide	17	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	17	suppressed
Trulicity	Dulaglutide	17	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	14
Diltiazem 24hr Er	Diltiazem Hcl	16	suppressed
Fenofibrate	Fenofibrate	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Myrbetriq	Mirabegron	16	suppressed
Verapamil Er	Verapamil Hcl	16	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	15	suppressed
Linzess	Linaclotide	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Azithromycin	Azithromycin	14	12
Fluticasone Propionate Hfa	Fluticasone Propionate	14	suppressed
Latanoprost	Latanoprost	14	suppressed
Meclizine Hcl	Meclizine Hcl	14	11
Risedronate Sodium	Risedronate Sodium	14	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	13	suppressed
Flunisolide	Flunisolide	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Nystop	Nystatin	13	suppressed
Propranolol Hcl Er	Propranolol Hcl	13	suppressed
Rasagiline Mesylate	Rasagiline Mesylate	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Fluticasone-Vilanterol	Fluticasone/Vilanterol	12	suppressed
Lactulose	Lactulose	12	suppressed
Mexiletine Hcl	Mexiletine Hcl	12	suppressed
Mupirocin	Mupirocin	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Telmisartan	Telmisartan	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	11	suppressed
Aripiprazole	Aripiprazole	11	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	11	suppressed
Dexlansoprazole Dr	Dexlansoprazole	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Yuvafem	Estradiol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error